Litcius/Paper detail

Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritis

Corrado Campochiaro, Alessandro Tomelleri, Silvia Sartorelli, Giulio Cavalli, Giacomo De Luca, Elena Baldissera, Lorenzo Dagna

2020Seminars in Arthritis and Rheumatism34 citationsDOI

Topics & Concepts

MedicineTocilizumabAdalimumabInfliximabConcomitantDiscontinuationInternal medicineGolimumabAnakinraAbataceptEtanerceptHazard ratioGastroenterologySurgeryRheumatoid arthritisRituximabDiseaseConfidence intervalLymphomaVasculitis and related conditionsRenal Diseases and GlomerulopathiesRheumatoid Arthritis Research and Therapies
Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritis | Litcius